SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-008781
Filing Date
2018-06-15
Accepted
2018-06-15 16:15:40
Documents
6
Period of Report
2018-06-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28546
2 ex99-1.htm EX-99.1 4284
3 image_001.jpg GRAPHIC 181300
4 image_002.jpg GRAPHIC 236942
5 image_003.jpg GRAPHIC 89206
6 image_004.jpg GRAPHIC 91305
  Complete submission text file 0001493152-18-008781.txt   859031
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 18902365
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1